SEI — Qualitative And Quantitative Hepatitis B Virus Antibody Assays Class II
FDA product code SEI covers "Qualitative And Quantitative Hepatitis B Virus Antibody Assays", a Class II medical device regulated under 21 CFR 866.3173. Submissions are reviewed by the Microbiology panel. At least 4 recent 510(k) clearances have been granted under this product code.
Classification Details
- Product Code
- SEI
- Device Class
- Class II
- Regulation Number
- 866.3173
- Submission Type
- Review Panel
- MI
- Medical Specialty
- Microbiology
- Implant
- No
Definition
In vitro diagnostic devices intended for use in the detection of antibodies to HBV. These devices are intended to aid in the diagnosis of HBV infection in persons with signs and symptoms of hepatitis and in persons at risk for HBV infection. Anti-HBs assay results may be used as an aid in the determination of susceptibility to HBV infection in individuals prior to or following HBV vaccination or when vaccination status is unknown.